Generic name: Nepafenac 3mg in 1mL
Dosage form: ophthalmic suspension
Medically reviewed on December 12, 2017.
One drop of ILEVRO* (nepafenac ophthalmic suspension), 0.3% should be applied to the affected eye one-time-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. An additional drop should be administered 30 to 120 minutes prior to surgery.
Use with Other Topical Ophthalmic Medications
ILEVRO* (nepafenac ophthalmic suspension), 0.3% may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Ilevro (nepafenac ophthalmic)
Other brands: Nevanac